We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Siemens Healthineers - Laboratory Diagnostics

Provides advanced laboratory diagnostics solutions for the medical industry read more Featured Products: More products

Download Mobile App





Siemens Showcases Broad Portfolio of Integrated IVD Solutions at EUROMEDLAB Munich

By LabMedica International staff writers
Posted on 11 Apr 2022
Print article
Image: epoc® Blood Analysis System (Photo courtesy of Siemens Healthineers)
Image: epoc® Blood Analysis System (Photo courtesy of Siemens Healthineers)

Siemens Healthineers (Erlangen, Germany) showcased its broad portfolio of integrated IVD solutions at EUROMEDLAB 2022 which was held 10th-14th April 2022 in Munich, Germany.

At EUROMEDLAB Munich, Siemens demonstrated it automation solutions for labs of all sizes that are fully scalable, innovative, and customized for individual workflows. Siemens demonstrated how labs could achieve open, one-touch, end-to-end testing with its Aptio Automation solution and drive open, one-touch sample preparation for multidisciplinary labs with its Atellica Task Targeted Automation solution. The company also demonstrated how its Atellica Integrated Automation solution could streamline the biggest chemistry and immunoassay workloads for laboratories.

The company showcased its two new high-volume hematology analyzers - Atellica HEMA 570 and 580 - designed to meet the hematology testing needs of today’s high-volume labs. Sharing fast throughput and an identical footprint, both instruments are intended to pair with advanced informatics and automation solutions to suit diverse workflow requirements and drive efficiencies across labs and networks. Each delivers a range of analytical capabilities, including an 8-part white blood cell differential, with the Atellica HEMA 580 Analyzer offering an expanded menu complete with optical platelet and reticulocyte testing. In addition, Siemens highlighted its epoc Blood Analysis System with epoc NXS Hos, the market-first Android powered patient-side testing solution. epoc is a handheld, wireless solution to enable comprehensive blood analysis testing at the patient’s side on a single room temperature test card, with results in less than a minute.

Siemens also displayed the Dimension EXL 200 Integrated Chemistry System which can simplify operations with an integrated chemistry and immunoassay analyzer in a compact footprint. Also on display were the Sysmex CN-3000 and CN-6000 fully automated, mid- and high-volume coagulation analyzers that are designed to tackle big lab challenges. In addition, Siemens exhibited the new Atellica DCA connected, scalable, and portable analyzer that can collect actionable HbA1c and ACR results in minutes, alongside the Atellica CI 1900 System which is being developed for lower- to mid-volume laboratories. Among its high-performing assays, Siemens showcased the breadth and depth of its clinical menu from cardiac and allergy testing to dedicated plasma protein/FLC to real-time PCR testing for SARS-CoV-2, new preeclampsia markers and more.

Related Links:
Siemens Healthineers 

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Researchers have found the first evidence of testing for the alpha-synuclein protein in blood samples via seed amplification assay (Photo courtesy of Shutterstock)

Blood Test to Detect Alpha-Synuclein Protein Could Revolutionize Parkinson's Disease Diagnostics

Currently, Parkinson's disease (PD) is identified through clinical diagnosis, typically at a later stage in the disease's progression. There is a pressing need for an objective and quantifiable biomarker... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: Ultra-Rapid Antimicrobial Susceptibility Testing (uRAST) revolutionizing traditional antibiotic susceptibility testing (Photo courtesy of Seoul National University)

Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours

Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more

Pathology

view channel
Image: The AI model can distinguish different stages of DCIS from inexpensive and readily available breast tissue images (Photo courtesy of David A. Litman/Shutterstock)

AI Model Identifies Breast Tumor Stages Likely To Progress to Invasive Cancer

Ductal carcinoma in situ (DCIS) is a non-invasive type of tumor that can sometimes progress to a more lethal form of breast cancer and represents about 25% of all breast cancer cases. Between 30% and 50%... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.